Nuvectis Pharma Inc
(NVCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,943 | -12,890 | -10,629 | -5,961 | -23 |
| Other Working Capital | -289 | 1,494 | 485 | 379 | 23 |
| Other Operating Activity | 156 | 1,892 | 1,707 | 1,571 | 0 |
| Operating Cash Flow | $-3,076 | $-9,504 | $-8,437 | $-4,011 | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,000 | N/A | 0 | 0 | N/A |
| Other Financing Activity | -1,973 | 15,246 | 15,246 | 11,225 | 0 |
| Financing Cash Flow | $14,027 | $15,246 | $15,246 | $11,225 | $N/A |
| Beginning Cash Position | 5,742 | 0 | N/A | N/A | N/A |
| End Cash Position | 16,693 | 5,742 | 6,809 | 7,214 | N/A |
| Net Cash Flow | $10,951 | $5,742 | $6,809 | $7,214 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,076 | -9,504 | -8,437 | -4,011 | N/A |
| Free Cash Flow | -3,076 | -9,504 | -8,437 | -4,011 | 0 |